Description

Brivaracetam (Racemate) CAS NO 357335-87-6 is a high-purity chemical compound belonging to the racetam class of nootropic agents. This material serves as a critical intermediate and reference standard in the research and development of novel central nervous system (CNS) therapeutics. It is primarily utilized by pharmaceutical R&D laboratories, academic research institutions, and analytical service providers. The compound's significance lies in its role for comparative studies, method development, and quality control within the neuropharmacology sector.

Application

• Pharmaceutical Reference Standard: Used as a certified reference material (CRM) for analytical method validation, quality control, and regulatory submissions in drug development.
• Active Pharmaceutical Ingredient (API) Intermediate: Serves as a key synthetic precursor in the production of Brivaracetam and related enantiomerically pure compounds.
• Neurological Research: Employed in preclinical and in-vitro studies to investigate mechanisms of action related to synaptic vesicle protein 2A (SV2A) binding and antiepileptic activity.
• Metabolite and Impurity Synthesis: Used in the synthesis of process-related impurities and degradation products for stability-indicating method development.
• Analytical Chemistry: Acts as a calibration standard in high-performance liquid chromatography (HPLC), mass spectrometry (MS), and other spectroscopic techniques.
• Academic and Contract Research: Supplied to universities and CROs (Contract Research Organizations) for fundamental pharmacological research and screening assays.

Basic Information

Product Name	Brivaracetam (Racemate)
CAS No.	357335-87-6
Molecular Formula	C11H20N2O2
Molecular Weight	212.29 g/mol
Synonyms	(2S)-2-[(4R)-2-Oxo-4-propylpyrrolidin-1-yl]butanamide (Racemate); UCB 34714; Brivaracetam Racemic Mixture; (RS)-Brivaracetam; (±)-Brivaracetam; 1-[(2S)-2-Aminobutanoyl]-4-propyl-DL-prolin-2-one; 4-Propyl-DL-proline, 1-[(2S)-2-aminobutanoyl]-2-oxo-
EINECS	Contact for details

Quality Control

Our Brivaracetam (Racemate) is manufactured under strict quality management systems. Each batch undergoes comprehensive analytical testing to ensure identity, purity, and consistency, meeting the stringent requirements for pharmaceutical research and development. A detailed Certificate of Analysis (COA) is provided with every shipment, documenting results for key parameters including assay, enantiomeric purity, and related substances. We adhere to cGMP (current Good Manufacturing Practice) guidelines where applicable to support our global clientele in regulated markets.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). This product is hygroscopic (moisture-sensitive) and should be handled in a dry environment to prevent degradation. For long-term storage, consider desiccants or inert atmosphere conditions.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time matches reference standard
Assay (HPLC)	≥ 98.0%
Enantiomeric Purity (Chiral HPLC)	≤ 1.0% of each enantiomer
Related Substances (HPLC)	Total impurities ≤ 2.0% Any single unknown impurity ≤ 0.5%
Residual Solvents (GC)	Complies with ICH Q3C guidelines
Water Content (KF)	≤ 1.0%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.